USPTO serial 79138122
MYMEDS&ME
Reviewed by CopyMark Law Group
Reg. 4607742Status 709
- Filing date
- Status date
- Registration date
- Sep 23, 2014
- Examiner
- SOBRAL, CHRISTINA
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MYMEDS&ME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia A. Moyer
Cynthia A. Moyer Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information concerning the quality, safety and effectiveness of medications and/or pharmaceuticals and reactions and events resulting from the use of medications and/or pharmaceuticals; computer software for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning the quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events; computer software applications for capturing information concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality, safety and effectiveness of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication and/or pharmaceuticals | SECTION 71 - CANCELLED | — |
| 038 | Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunication; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunication services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies | SECTION 71 - CANCELLED | — |
| 042 | software as a service (SAAS) services featuring software for capturing and providing data concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analysing data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication or pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use medication and/or pharmaceuticals, as well as enabling followup questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning the quality of medication and/or pharmaceuticals used, reactions and events resulting from the use of medication and/or pharmaceuticals, answer (and read answers to) follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analysing data concerning the quality of medication and/or pharmaceuticals used, reactions and events resulting from the use of medication and/or pharmaceuticals | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MyMedsandMe Limited
- Other trademarks owned by MyMedsandMe Limited
- Other trademarks owned by MyMedsandMe Limited
- Other trademarks in Class 009
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named MYMEDS&ME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 6, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 6, 2026 | C71T | CANCELLED SECTION 71 | — |
| Sep 23, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Aug 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 3, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 12, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| May 12, 2021 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jan 5, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 23, 2020 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 13, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 26, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 26, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 23, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 23, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 8, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 2, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 18, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| May 31, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 31, 2014 | ALIE | ASSIGNED TO LIE | — |
| May 19, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 16, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 10, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 19, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 15, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 14, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 14, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 13, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 11, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |